Trypsin disrupts the trafficking of the human dopamine transporter by α-synuclein and its A30P mutant

被引:35
|
作者
Wersinger, C
Vernier, P
Sidhu, A
机构
[1] Georgetown Univ, Dept Pediat, Washington, DC 20007 USA
[2] CNRS, Inst Neurobiol Alfred Fessard, F-91198 Gif Sur Yvette, France
关键词
D O I
10.1021/bi035308s
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
alpha-Synuclein modulates dopamine homeostasis in dopamine-producing neurons of substantia nigra, partly through regulation of human dopamine transporter (hDAT) activity. To identify the underlying mechanisms, we disrupted the modulation of hDAT activity by wild-type (wt) alpha-synuclein, and its familial Parkinson's disease linked mutants A30P and A53T, by mild trypsinization (0.1%, 30 s) of Ltk-cotransfected cells. Trypsin completely reversed the attenuation of hDAT function mediated by wt and the A30P mutant. In A53T coexpressing cells, where DAT activity is not downregulated, trypsinization did not induce any changes. These effects of trypsin were mimicked by collagenase I and Dispase (0.1%, 1 min each) but not by chymotrypsin, Pronase, or papain (0.1%, up to 2 min each). Trypsin increased dopamine uptake in rat primary mesencephalic neurons, suggesting that DAT activity is also subjected to modulation by alpha-synuclein in these neurons that endogenously coexpress both proteins. In trypsinized cells, dopamine accelerated both production of reactive oxygen species and cell death in hDAT and wt or A30P, but not A53T, coexpressing cells, compared to nontrypsinized cells. Paradoxically, trypsin increased the protein-protein interactions between the synuclein variants and hDAT, without any noticeable proteolysis of these proteins. hDAT-alpha-synuclein protein-protein interactions occurred through residues 58-107 (NAC domain) of the alpha-synuclein variants and residues 598-620 of the carboxy-terminal tail of hDAT, in both trypsinized and nontrypsinized cells. Confocal microscopy and biotinylation studies show that, in cells expressing the wt or A30P variants, but not the A53T mutant, hDAT is sequestered away from the plasma membrane into the cytoplasm, an effect that is reversed by trypsin. These results show that alpha-synuclein modulates hDAT function through trafficking of the transporter in a process that can be disrupted by trypsin.
引用
收藏
页码:1242 / 1253
页数:12
相关论文
共 50 条
  • [1] α-Synuclein and Its A30P Mutant Affect Actin Cytoskeletal Structure and Dynamics
    Sousa, Vitor L.
    Bellani, Serena
    Giannandrea, Maila
    Yousuf, Malikmohamed
    Valtorta, Flavia
    Meldolesi, Jacopo
    Chieregatti, Evelina
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2009, 20 (16) : 3725 - 3739
  • [2] Conversion of Wild-type α-Synuclein into Mutant-type Fibrils and Its Propagation in the Presence of A30P Mutant
    Yonetani, Motokuni
    Nonaka, Takashi
    Masuda, Masami
    Inukai, Yuki
    Oikawa, Takayuki
    Hisanaga, Shin-ichi
    Hasegawa, Masato
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (12) : 7940 - 7950
  • [3] Expression of A30P mutant α-synuclein impairs macroautphagy in PC 12 cells
    Yan, Jia-qing
    Yuan, Yu-he
    Chen, Nai-hong
    [J]. ACTA PHARMACOLOGICA SINICA, 2013, 34 : 118 - 118
  • [4] Conserved core of amyloid fibrils of wild type and A30P mutant α-synuclein
    Cho, Min-Kyu
    Kim, Hai-Young
    Fernandez, Claudio O.
    Becker, Stefan
    Zweckstetter, Markus
    [J]. PROTEIN SCIENCE, 2011, 20 (02) : 387 - 395
  • [5] Defective membrane interactions of familial Parkinson's disease mutant A30P α-synuclein
    Jo, EJ
    Fuller, N
    Rand, RP
    St George-Hyslop, P
    Fraser, PE
    [J]. JOURNAL OF MOLECULAR BIOLOGY, 2002, 315 (04) : 799 - 807
  • [6] First Appraisal of Brain Pathology Owing to A30P Mutant Alpha-Synuclein
    Seidel, Kay
    Schoels, Ludger
    Nuber, Silke
    Petrasch-Parwez, Elisabeth
    Gierga, Kristin
    Wszolek, Zbigniew
    Dickson, Dennis
    Gai, Wei P.
    Bornemann, Antje
    Riess, Olaf
    Rami, Abdelhaq
    den Dunnen, Wilfried F. A.
    Deller, Thomas
    Rueb, Udo
    Krueger, Rejko
    [J]. ANNALS OF NEUROLOGY, 2010, 67 (05) : 684 - 689
  • [7] Wildtype and A30P Mutant Alpha-Synuclein Form Different Fibril Structures
    Nielsen, Soren Bang
    Macchi, Francesca
    Raccosta, Samuele
    Langkilde, Annette Eva
    Giehm, Lise
    Kyrsting, Anders
    Svane, Anna Sigrid Pii
    Manno, Mauro
    Christiansen, Gunna
    Nielsen, Niels Christian
    Oddershede, Lene
    Vestergaard, Bente
    Otzen, Daniel Erik
    [J]. PLOS ONE, 2013, 8 (07):
  • [8] Increased sensitivity to MPTP in human α-synuclein A30P transgenic mice
    Nieto, María
    Gil-Bea, Francisco J.
    Dalfó, Esther
    Cuadrado, Mar
    Cabodevilla, Felipe
    Sanchez, Belén
    Catena, Silvia
    Sesma, Teresa
    Ribe, Elena
    Ferrer, Isidro
    Ramirez, María J.
    Gomez-Isla, Teresa
    [J]. NEUROBIOLOGY OF AGING, 2006, 27 (06) : 848 - 856
  • [9] Mice Expressing A53T/A30P Mutant Alpha-Synuclein in Dopamine Neurons Do Not Display Behavioral Deficits
    Keomanivong, Cameron
    Schamp, Josephine
    Tabakovic, Ervina
    Thangavel, Ramasamy
    Aldridge, Georgina
    Pieper, Andrew A.
    Narayanan, Nandakumar S.
    [J]. ENEURO, 2024, 11 (02) : 16 - 16
  • [10] Trichloroethylene and its metabolite TaClo lead to degeneration of substantia nigra dopaminergic neurones: Effects in wild type and human A30P mutant α-synuclein mice
    Keane, P. C.
    Hanson, P. S.
    Patterson, L.
    Blain, P. G.
    Hepplewhite, P.
    Khundakar, A. A.
    Judge, S. J.
    Kahle, P. J.
    LeBeau, F. E. N.
    Morris, C. M.
    [J]. NEUROSCIENCE LETTERS, 2019, 711